Fractyl Health, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Fractyl Health, Inc. is holding a special meeting on September 24, 2026, to seek stockholder approval for a reverse stock split ranging from 1-for-5 to 1-for-15 to maintain its Nasdaq listing.
NASDAQ
Fractyl Health announces its 2026 Annual Meeting of Stockholders to be held virtually on June 10, 2026.
NASDAQ
Fractyl Health, Inc. will hold a special meeting on October 3, 2025, to seek stockholder approval for the issuance of common stock upon the exercise of Tranche B Warrants, crucial for funding its pipeline programs and extending its cash runway.
NASDAQ
Fractyl Health, Inc. has filed a definitive proxy statement with the SEC, soliciting material under Section 240.14a-12.
NASDAQ
Fractyl Health announces its 2025 Annual Meeting of Stockholders to be held virtually on June 11, 2025, featuring proposals for director elections and ratification of the company's independent auditor.